Publications by authors named "Jason Knight"

Claim this Profile
L
Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression.
Ashley N Pearson, Jessica Waninger, Amanda K Huber, Erin A Holcomb, Jadyn G James, Jason S Knight

Cancer Immunol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome.
Bruna de Moraes Mazetto Fonseca, Somanathapura K NaveenKumar, Srilakshmi Yalavarthi, Kavya Sugur, Thalia G Newman, Jason S Knight

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole-blood RNA transcriptome.
Amala Ambati, Feiyang Ma, Katarina Kmetova, Sherwin Navaz, Claire K Hoy, Jason S Knight

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target.
Somanathapura K NaveenKumar, Thalia G Newman, Bruna Mazetto Fonseca, Srilakshmi Yalavarthi, Mariane C Flores Nascimento, Jason S Knight

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.
Hui Shi, Wenying Liang, Zhixia Yang, Claire K Hoy, Qiuyu Wang, Jason S Knight

Circulation· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils take center stage in VEXAS syndrome pathogenesis.
Ajay Tambralli, Jason S Knight

J Clin Invest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry.
Alexander Pine, Ayesha Butt, Laura Andreoli, Jason S Knight, Maria Gerosa

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac pathology in a patient with a novel pathogenic variant c.703del (p.Ile235SerfsTer4) of the TAFAZZIN gene.
Marisa Prasanpanich, Majid Husain, Nancy J Halnon, Richard Chang, Neda Zadeh, Jason Knight

Cardiovasc Pathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular Disease.
Yu Zuo, Somanathapura K NaveenKumar, Sherwin Navaz, Wenying Liang, Kavya Sugur, Jason S Knight

JAMA Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Review: Neutrophil Extracellular Traps and Antiphospholipid syndrome.
Ayesha Butt, Anish Sharda, Alfred Ian Lee, Jason S Knight

Transfus Med Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Mortality in Antiphospholipid Antibody-Positive Patients: Prospective Results From Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking Clinical Database and Repository.
Yasaman Ahmadzadeh, Larry S Magder, Danieli Castro Oliveira de Andrade, Diana Paredes-Ruiz, Maria G Tektonidou, Jason S Knight

Arthritis Care Res (Hoboken)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of children who received rapid genomic sequencing.
Erica Sanford Kobayashi, Laura E Tobin, Madison Arenchild, Wendy Benson, Nicole G Coufal, Jason Knight

Genet Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation.
Kris M Blair, Dillon J Bohinc, Kara L Bane, Mark Warnock, Basel Abuaita, Jason S Knight

Circ Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.
D Ware Branch, Mimi Y Kim, Marta M Guerra, Joseph Worden, Carl A Laskin, Jason S Knight

Ann Rheum Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry").
Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Jason S Knight

Rheumatology (Oxford)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.
Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, Gautam Sule, Carmelo Carmona-Rivera, Jason S Knight

JCI Insight· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities.
Thalia G Newman, Jason S Knight

Arthritis Rheumatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis.
Mariana González-Treviño, Gabriel Figueroa-Parra, Jeffrey X Yang, Larry J Prokop, Sherif M Gamal, Jason S Knight

Rheumatology (Oxford)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mimetic Assay of Neutrophil Extracellular Trap Degradation Using YOYO-1-Stained DNA-Histone Surface Webs.
Katherine H Nguyen, Midori L Wasielewski, Srilakshmi Yalavarthi, Xianggui Qu, Jason S Knight

Cells· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil prime unique transcriptional responses in intestinal organoids during infection with nontyphoidal serovars.
Anna-Lisa E Lawrence, Ryan P Berger, David R Hill, Sha Huang, Veda K Yadagiri, Jason S Knight

mSphere· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome.
Desiré Casares-Marfil, Manuel Martínez-Bueno, Maria Orietta Borghi, Guillermo Pons-Estel, , Jason S Knight

Arthritis Rheumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can transcriptomics guide the management of SLE-associated APS?
Jason S Knight, Maria G Tektonidou

Nat Rev Rheumatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated neutrophil extracellular traps in systemic sclerosis-associated vasculopathy and suppression by a synthetic prostacyclin analog.
Neda Kortam, Wenying Liang, Claire Shiple, Suiyuan Huang, Rosemary Gedert, Jason S Knight

Arthritis Res Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking antiphospholipid syndrome to guide future management and research.
Jason S Knight, Doruk Erkan

Nat Rev Rheumatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome.
Ajay Tambralli, Alyssa Harbaugh, Somanathapura K NaveenKumar, Megan D Radyk, Christine E Rysenga, Jason S Knight

J Clin Invest· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis